Cancer stem cell-related markers, CD44, ABCG2, BMI1, and KRT19, expression in subclusters from trajectory, indicated enhanced self-renewal capacity in SRGN-high malignant cells (Figure 5F). This evidence concerns the gene ABCG2 and cancer.